Tech Company Financing Transactions
ElevateBio Funding Round
On 3/16/2021, ElevateBio secured $525 million in Series C investment from Fidelity Management & Research Company, Matrix Capital Management and SoftBank Group.
Transaction Overview
Company Name
Announced On
3/16/2021
Transaction Type
Venture Equity
Amount
$525,000,000
Round
Series C
Proceeds Purpose
This new funding will be used to help the company expand its R&D and manufacturing capabilities, as well as continue to spin out new companies and partnerships based on its research.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
139 Main St. 500
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
Email Address
Overview
ElevateBio is creating and operating a portfolio of cell and gene therapy companies through partnerships with the world's most innovative scientists and inventors. Together, we leverage our internal bench-to-bedside expertise and to accelerate the development and delivery of therapies -- supported by our broad access to capital.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 3/16/2021: UpSwot venture capital transaction
Next: 3/16/2021: Stripe venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs